Why in news?
Budget 2026-27 proposes three new Chemical Parks with Rs 600 crore for infrastructure, building on the Bulk Drug Parks' success but focused on chemicals.
About
The Bulk Drug Park Scheme is a Government of India initiative launched in 2020 to boost domestic manufacturing of Active Pharmaceutical Ingredients (APIs), reduce import dependence, and ensure affordable drug supply security. It provides financial support to states for setting up common infrastructure facilities in dedicated industrial parks, with a total outlay of ₹3,000 crore.
Key Features of the Bulk Drug Park Scheme
- Launch Year: 2020 by the Department of Pharmaceuticals, Ministry of Chemicals & Fertilizers.
- Objective:
- Strengthen domestic API production.
- Reduce reliance on imports (especially from China).
- Lower production costs and ensure uninterrupted medicine supply.
- Financial Outlay: ₹3,000 crore allocated for the scheme.
- Support Mechanism: Grants-in-aid to states for creating common infrastructure facilities such as:
- Effluent treatment plants
- Solid waste management systems
- Common testing centers
- Warehousing and logistics facilities
- Power and steam generation units
Implementation Structure
- Number of Parks: Up to three Bulk Drug Parks to be established across India.
- Selection Process: States compete through a challenge method; proposals are evaluated based on readiness, land availability, and environmental compliance.
- Funding Pattern:
- Government of India provides up to 70% of project cost (90% for North-Eastern and hilly states).
- Remaining cost borne by the state government.
Impact and Significance
- Drug Security: Ensures continuous supply of essential medicines.
- Economic Benefits: Reduces import bill and strengthens India’s pharmaceutical competitiveness globally.
- Employment: Generates jobs in pharma manufacturing and allied sectors.
- Healthcare Access: Helps keep medicine prices affordable for citizens.
Challenges & Risks
- Environmental Concerns: Bulk drug manufacturing generates high chemical waste; strict compliance needed.
- Global Competition: APIs from China remain cheaper due to economies of scale.
- Implementation Delays: Land acquisition and infrastructure setup may slow progress.
Download Pdf
